Who
Nancy C. Andrews
Director
Company insider
Files Form 4 as: Director, Charles River Laboratories International; Director, Maze Therapeutics.
In numbers
- Trades disclosed
- 29
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $327K
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 2 Mar 2020
- Last trade
- 18 Aug 2026
- Last filed
- 20 Aug 2026
Companies traded
Activity over time
1 Aug – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 18 Aug 2026filed 20 Aug 2026 | CRL Charles River Laboratories InternationalLife-science tools | SEC FORM 4 Code M | $94K573 at $164.30 | filing |
| 18 Aug 2026filed 20 Aug 2026 | CRL Charles River Laboratories InternationalLife-science tools | SEC FORM 4 Sold | $163K573 at $285.24 | filing |
| 18 Aug 2026filed 20 Aug 2026 | CRL Charles River Laboratories Internationaloption or derivative · Life-science tools | SEC FORM 4 Code M | —573 at $0.00 | filing |
| 18 Aug 2026filed 20 Aug 2026 | CRL Charles River Laboratories Internationaloption or derivative · Life-science tools | SEC FORM 4 Code M | —573 at $0.00 | filing |
| 18 Aug 2026filed 20 Aug 2026 | CRL Charles River Laboratories InternationalLife-science tools | SEC FORM 4 Code M | $94K573 at $164.30 | filing |
| 18 Aug 2026filed 20 Aug 2026 | CRL Charles River Laboratories InternationalLife-science tools | SEC FORM 4 Sold | $163K573 at $285.24 | filing |
| 8 Jun 2026filed 10 Jun 2026 | MAZE Maze Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —18,000 at $0.00 | filing |
| 8 Jun 2026filed 10 Jun 2026 | MAZE Maze Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —18,000 at $0.00 | filing |
| 12 May 2026filed 14 May 2026 | CRL Charles River Laboratories InternationalLife-science tools | SEC FORM 4 Code G | —3,964 at $0.00 | filing |
| 12 May 2026filed 14 May 2026 | CRL Charles River Laboratories InternationalLife-science tools | SEC FORM 4 Code G | —3,964 at $0.00 | filing |
| 12 May 2026filed 14 May 2026 | CRL Charles River Laboratories InternationalLife-science tools | SEC FORM 4 Code G | —3,964 at $0.00 | filing |
| 12 May 2026filed 14 May 2026 | CRL Charles River Laboratories InternationalLife-science tools | SEC FORM 4 Code G | —3,964 at $0.00 | filing |
| 8 May 2026filed 11 May 2026 | CRL Charles River Laboratories InternationalLife-science tools | SEC FORM 4 Code A | $255K1,438 at $177.62 | filing |
| 8 May 2026filed 11 May 2026 | CRL Charles River Laboratories InternationalLife-science tools | SEC FORM 4 Code A | $255K1,438 at $177.62 | filing |
| 22 Sep 2025filed 24 Sep 2025 | MAZE Maze Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —18,000 at $0.00 | filing |
| 21 May 2025filed 23 May 2025 | CRL Charles River Laboratories Internationaloption or derivative · Life-science tools | SEC FORM 4 Code A | $280K2,076 at $134.98 | filing |
| 21 May 2025filed 23 May 2025 | CRL Charles River Laboratories InternationalLife-science tools | SEC FORM 4 Code A | $128K946 at $134.98 | filing |
| 13 May 2024filed 15 May 2024 | CRL Charles River Laboratories Internationaloption or derivative · Life-science tools | SEC FORM 4 Code A | $299K1,311 at $228.41 | filing |
| 13 May 2024filed 15 May 2024 | CRL Charles River Laboratories InternationalLife-science tools | SEC FORM 4 Code A | $128K559 at $228.41 | filing |
| 15 May 2023filed 17 May 2023 | CRL Charles River Laboratories Internationaloption or derivative · Life-science tools | SEC FORM 4 Code A | $321K1,669 at $192.36 | filing |
News
Charles River Laboratories International, Inc. $CRL Stock: Yousif Capital Management LLC Boosts HoldingsCRL · dailypolitical.com · 24 Oct 2026Charles River Laboratories International (NYSE:CRL) versus VivoSim Labs (NASDAQ:VIVS) Head-To-Head ContrastCRL · dailypolitical.com · 22 Oct 2026
0 headlines in the last 90 days name Nancy C. Andrews; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.